Back to search
FDAFDA · Food and drugs·Recall number D-0379-2021

Asenapine Sublingual Tablets, 5 mg, Rx Only, 60 Tablets, Sigmapharm Laboratories, LLC, Bensalem, PA, 19020 NDC 42794-016-10.

Published May 26, 2021 · Recall initiated: April 19, 2021

Summary

FDA records drug Class III recall D-0379-2021, published May 26, 2021 and initiated April 19, 2021. Recalling firm: SigmaPharm Laboratories LLC; Status: Terminated; Reported quantity: 6266 bottles; Lot: Lots # 2012501, 2012601 , 2012701, & 2100701, Exp. AUG 2022. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Incorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavoring agent instead of Art Black Cherry Flavor flavoring agent

What to do

Voluntary: Firm initiated · Letter

Get an email if ASENAPINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ASENAPINE
Manufacturer
SigmaPharm Laboratories LLC
Distributor
Nationwide in the US
UPC
0342794016103
Lot
Lots # 2012501, 2012601 , 2012701, & 2100701, Exp. AUG 2022
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Asenapine Sublingual Tablets, 5 mg, Rx Only, 60 Tablets, Sigmapharm Laboratories, LLC, Bensalem, PA, 19020 NDC 42794-016-10. recalled?

Yes. FDA published recall D-0379-2021 on May 26, 2021. Reported hazard: Incorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavoring agent instead of Art Black Cherry Flavor flavoring agent

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ASENAPINE. UPC: 0342794016103.